Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 5Unknown 3Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Amenorrhea 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Postoperative Period × Clear all
NCT02075060 2017-04-06

IPOI vs IPOP

Poitiers University Hospital

Phase 2 Unknown
54 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Unknown
600 enrolled
Breast

Amenorrhea, Breast Neoplasms

NCT00654342 2008-04-08

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Chung-Ang University

Phase NA Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡